Artigo Acesso aberto Revisado por pares

American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care

2020; Lippincott Williams & Wilkins; Volume: 39; Issue: 2 Linguagem: Inglês

10.1200/jco.20.02953

ISSN

1527-7755

Autores

Nathan A. Pennell, Melissa S. Dillmon, Laura A. Levit, E. Allyn Moushey, Ajjai Alva, Sibel Blau, Timothy Lewis Cannon, N Dickson, Maximilian Diehn, Mithat Gönen, Maria Magdalena González, Jack O. Hensold, Leslie Hinyard, Tari A. King, Stacie Lindsey, Allison Magnuson, Jonathan M. Marron, Barbara Mcaneny, Theresa Margaret McDonnell, Kathryn F. Mileham, S Nasso, Grzegorz S. Nowakowski, Kurt R. Oettel, Manali I. Patel, Debra A. Patt, Jane Perlmutter, Todd Pickard, Gladys Rodriguez, Abby R. Rosenberg, Barry Russo, Connie M. Szczepanek, Cardinale B. Smith, Piyush Srivastava, Eleonora Teplinsky, Ramya Thota, Tiffany A. Traina, Robin Zoň, Brian Bourbeau, Suanna S. Bruinooge, Shelagh E. Foster, Stephen Grubbs, Karen L. Hagerty, Patricia A. Hurley, Deborah Y. Kamin, Jonathan Phillips, Caroline Schenkel, Richard L. Schilsky, Howard A. Burris,

Tópico(s)

Health Systems, Economic Evaluations, Quality of Life

Resumo

This report presents the American Society of Clinical Oncology's (ASCO's) evaluation of the adaptations in care delivery, research operations, and regulatory oversight made in response to the coronavirus pandemic and presents recommendations for moving forward as the pandemic recedes. ASCO organized its recommendations for clinical research around five goals to ensure lessons learned from the COVID-19 experience are used to craft a more equitable, accessible, and efficient clinical research system that protects patient safety, ensures scientific integrity, and maintains data quality. The specific goals are: (1) ensure that clinical research is accessible, affordable, and equitable; (2) design more pragmatic and efficient clinical trials; (3) minimize administrative and regulatory burdens on research sites; (4) recruit, retain, and support a well-trained clinical research workforce; and (5) promote appropriate oversight and review of clinical trial conduct and results. Similarly, ASCO also organized its recommendations regarding cancer care delivery around five goals: (1) promote and protect equitable access to high-quality cancer care; (2) support safe delivery of high-quality cancer care; (3) advance policies to ensure oncology providers have sufficient resources to provide high-quality patient care; (4) recognize and address threats to clinician, provider, and patient well-being; and (5) improve patient access to high-quality cancer care via telemedicine. ASCO will work at all levels to advance the recommendations made in this report.

Referência(s)
Altmetric
PlumX